Clinical Trial Update: Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) [Phase 2]

View source ↗

Summary

A Phase 2 trial completed evaluating the safety of two medications for treating hepatitis C in people with thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thalassemia

Snippet

Sponsor: Carelon Research | Conditions: Hepatitis C, Thalassemia | Phase 2 | Status: COMPLETED